Opus Genetics, Inc. — 424B5 Filings
28 424B5 filings on record
This page lists all 424B5 filings submitted to the SEC by Opus Genetics, Inc. (IRD), sorted by most recent first. Each row links to the full filing on EdgarLookup. Opus Genetics, Inc. has filed 28 424B5 documents with the SEC since 2003. To view all SEC filings by Opus Genetics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10KSB
10QSB
144
25
3
4
4/A
424A
424B3
424B4
424B5
425
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERT
CERTAMX
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
DEFC14A
DEFM14A
DEFR14A
DFAN14A
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
PRE 14C
PREC14A
PRER14A
PRER14C
PRRN14A
PX14A6G
REGDEX
S-3
S-3/A
S-4
S-4/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B5 | 424B5 | 0001140361-25-040671 | Nov 6, 2025 | — |
| 424B5 | 424B5 | 0001140361-25-023739 | Jun 26, 2025 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001140361-25-012357 | Apr 4, 2025 | — |
| 424B5 | 424B5 | 0001140361-25-009961 | Mar 24, 2025 | — |
| 424B5 | 424B5 | 0001140361-25-009727 | Mar 20, 2025 | — |
| 424B5 | 424B5 | 0001140361-25-000950 | Jan 13, 2025 | — |
| 424B5 | 424B5 | 0001140361-23-039413 | Aug 14, 2023 | — |
| 424B5 | FORM 424B5 | 0001140361-21-020071 | Jun 7, 2021 | — |
| 424B5 | 424B5 | 0001140361-21-008137 | Mar 11, 2021 | — |
| 424B5 | FORM 424(B)(5) | 0001140361-19-001517 | Jan 24, 2019 | — |
| 424B5 | 424B5 | 0001140361-19-001360 | Jan 22, 2019 | — |
| 424B5 | 424B5 | 0001140361-18-040882 | Oct 18, 2018 | — |
| 424B5 | 424B5 | 0001140361-17-038818 | Oct 17, 2017 | — |
| 424B5 | 424B5 | 0001140361-17-024482 | Jun 8, 2017 | — |
| 424B5 | REXAHN PHARMACEUTICALS, INC. 424B5 9-14-2016 | 0001140361-16-079921 | Sep 15, 2016 | — |
| 424B5 | REXAHN PHARMACEUTICALS, INC 424B5 2-26-2016 | 0001140361-16-055772 | Mar 1, 2016 | — |
| 424B5 | REXAHN PHARMACEUTICALS, INC 424B5 11-6-2015 | 0001140361-15-040306 | Nov 10, 2015 | — |
| 424B5 | REXAHN PHARMACEUTICALS, INC 424B5 11-5-2015 | 0001140361-15-039910 | Nov 6, 2015 | — |
| 424B5 | REXAHN PHARMACEUTICALS, INC 424B5 3-16-2015 | 0001140361-15-011987 | Mar 16, 2015 | — |
| 424B5 | REXAHN PHARMACEUTICALS INC 424B5 1-15-2014 | 0001140361-14-002552 | Jan 17, 2014 | — |
| 424B5 | REXAHN PHARMACEUTICALS, INC 424B5 1-16-2014 | 0001140361-14-002550 | Jan 17, 2014 | — |
| 424B5 | REXAHN PHARMACEUTICALS 424B5 10-10-2013 | 0001140361-13-038719 | Oct 15, 2013 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001193125-13-300699 | Jul 24, 2013 | — |
| 424B5 | 424B5 | 0001193125-12-486615 | Nov 30, 2012 | — |
| 424B5 | FORM 424(B)(5) | 0001193125-12-484631 | Nov 29, 2012 | — |
| 424B5 | REXAHN PHARMACEUTICALS INC 424B5 3-29-2011 | 0001140361-11-019286 | Mar 30, 2011 | — |
| 424B5 | REXAHN PHARMACEUTICALS 424B5 6-28-2010 | 0001140361-10-027239 | Jun 28, 2010 | — |
| 424B5 | REXAHN PHARMACEUTICALS 424B5 10-21-2009 | 0001140361-09-023616 | Oct 21, 2009 | — |